Compound ID | 1632
Class: Beta-lactamase inhibitor
| Agent Type: | Synthetic; Small molecule; Direct acting; Antibiotic adjuvant; |
| Spectrum of activity: | Gram-negative |
| Mechanism of action: | Beta-lactamase inhibitor |
| Target Pathogen: | Active against Escherichia coli expressing NDM-1 |
| Institute where first reported: | Northwest University, Xi'an, China |
| Year first mentioned: | 2019 |
| Development status: | Experimental |
| External links: | |
| Citation: | https://www.nature.com/articles/s41429-018-0121-4 |